Evidence map›Paper›PMID 39229781›Full record

ArticleFuture medicinal chemistry2024

Synthesis, cytotoxicity and

Marzieh Aghaei Khouzani, Zohreh Noaparast, Tina Asadi, Sajad Saeidi, Alireza Heidarnia, Behnoush Hamzeh Moghadam, Hanieh Mosavi Kia, Seyedeh Mahdieh Hashemi, Mohammad Mahdavi

Abstract read
In one paragraph

Article in Future medicinal chemistry, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Marzieh Aghaei KhouzaniEndocrinology & Metabolism Research Center, Endocrinology & Metabolism Clinical Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran.
Zohreh NoaparastDepartment of Radiopharmacy, Pharmaceutical Sciences Research Center, Faculty of Pharmacy, Mazandaran University of Medical Sciences, Sari.
Tina AsadiStudent Research Committee, Faculty of Pharmacy, Mazandaran University of Medical Sciences, Sari, Iran.
Sajad SaeidiStudent Research Committee, Faculty of Pharmacy, Mazandaran University of Medical Sciences, Sari, Iran.
Alireza HeidarniaStudent Research Committee, Faculty of Pharmacy, Mazandaran University of Medical Sciences, Sari, Iran.
Behnoush Hamzeh MoghadamStudent Research Committee, Faculty of Pharmacy, Mazandaran University of Medical Sciences, Sari, Iran.
Hanieh Mosavi KiaStudent Research Committee, Faculty of Pharmacy, Mazandaran University of Medical Sciences, Sari, Iran.
Seyedeh Mahdieh HashemiDepartment of Medicinal Chemistry, Pharmaceutical Sciences Research Center, Faculty of Pharmacy, Mazandaran University of Medical Sciences, Sari, Iran.ORCID 0000-0002-8889-4146
Mohammad MahdaviEndocrinology & Metabolism Research Center, Endocrinology & Metabolism Clinical Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran.

Funding

Mazandaran University of Medical Sciences 11860 and 14077
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Antineoplastic AgentsBenzothiazolesCell ProliferationTriazolesCell Line, TumorDrug Screening Assays, AntitumorHumansMolecular StructureStructure-Activity RelationshipTechnetium Tc 99m SestamibiThiazoles2-phenylbenzothiazoleAntineoplastic AgentsBenzothiazolesTechnetium Tc 99m SestamibiThiazolesTriazoles2-phenylbenzothiazole99mTc-MIBIanticancercellular uptaketriazole

Identifiers

PMID39229781
PMCPMC11485743

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.